<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>Diabetes Symptoms and treatment &#187; Diabetes Treatment</title>
	<atom:link href="http://diabetes-symptoms-treatment.com/category/treatment/feed/" rel="self" type="application/rss+xml" />
	<link>http://diabetes-symptoms-treatment.com</link>
	<description>Your resource for controlling diabetes</description>
	<pubDate>Sun, 13 May 2012 23:52:56 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Double-drug diabetes treatment disappoints in kids</title>
		<link>http://diabetes-symptoms-treatment.com/2012/05/double-drug-diabetes-treatment-disappoints-in-kids/</link>
		<comments>http://diabetes-symptoms-treatment.com/2012/05/double-drug-diabetes-treatment-disappoints-in-kids/#comments</comments>
		<pubDate>Thu, 03 May 2012 23:25:02 +0000</pubDate>
		<dc:creator>George</dc:creator>
		
		<category><![CDATA[Diabetes Treatment]]></category>

		<guid isPermaLink="false">http://diabetes-symptoms-treatment.com/2012/05/double-drug-diabetes-treatment-disappoints-in-kids/</guid>
		<description><![CDATA[


International Business Times


Double-drug diabetes treatment disappoints in kidsHealthNewsby Gene Emery and Nancy Lapid, Last updated April 30, 2012 NEW YORK (Reuters Health) - In a large new trial looking at ways to slow the progression of type 2 diabetes in children and teens, the addition of a second drug to the mainstay treatment &#8230;Aggressive diabetes [...]]]></description>
		<wfw:commentRss>http://diabetes-symptoms-treatment.com/2012/05/double-drug-diabetes-treatment-disappoints-in-kids/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Amylin Pharma rises on report of new sale talks</title>
		<link>http://diabetes-symptoms-treatment.com/2012/04/amylin-pharma-rises-on-report-of-new-sale-talks/</link>
		<comments>http://diabetes-symptoms-treatment.com/2012/04/amylin-pharma-rises-on-report-of-new-sale-talks/#comments</comments>
		<pubDate>Mon, 23 Apr 2012 20:23:32 +0000</pubDate>
		<dc:creator>George</dc:creator>
		
		<category><![CDATA[Diabetes Treatment]]></category>

		<guid isPermaLink="false">http://diabetes-symptoms-treatment.com/2012/04/amylin-pharma-rises-on-report-of-new-sale-talks/</guid>
		<description><![CDATA[


Bloomberg


Amylin Pharma rises on report of new sale talksCBS NewsTHE BIG PICTURE: Amylin sells the diabetes treatments Bydureon and Byetta. The company reportedly rejected a buyout offer from Bristol-Myers Squibb Co. earlier this year, and it is being sued by billionaire investor Carl Icahn.Amylin Said to Seek Buyers After Rejecting Bristol-MyersBloombergExclusive: Amylin explores sale, hires [...]]]></description>
		<wfw:commentRss>http://diabetes-symptoms-treatment.com/2012/04/amylin-pharma-rises-on-report-of-new-sale-talks/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Mouse Study Hints at New Path for Diabetes Treatment</title>
		<link>http://diabetes-symptoms-treatment.com/2012/04/mouse-study-hints-at-new-path-for-diabetes-treatment/</link>
		<comments>http://diabetes-symptoms-treatment.com/2012/04/mouse-study-hints-at-new-path-for-diabetes-treatment/#comments</comments>
		<pubDate>Fri, 13 Apr 2012 19:48:04 +0000</pubDate>
		<dc:creator>George</dc:creator>
		
		<category><![CDATA[Diabetes Treatment]]></category>

		<guid isPermaLink="false">http://diabetes-symptoms-treatment.com/2012/04/mouse-study-hints-at-new-path-for-diabetes-treatment/</guid>
		<description><![CDATA[


The Imperfect Parent


Mouse Study Hints at New Path for Diabetes TreatmentPhiladelphia InquirerBy Serena Gordon THURSDAY, April 12 (HealthDay News) &#8212; A potential new treatment for type 2 diabetes targets the hormone glucagon instead of insulin, according to a new study in mice. Although the research hasn&#39;t yet progressed past animal models of &#8230;New study reveals [...]]]></description>
		<wfw:commentRss>http://diabetes-symptoms-treatment.com/2012/04/mouse-study-hints-at-new-path-for-diabetes-treatment/feed/</wfw:commentRss>
		</item>
		<item>
		<title>GSK says diabetes treatment progressing in trials</title>
		<link>http://diabetes-symptoms-treatment.com/2012/04/gsk-says-diabetes-treatment-progressing-in-trials/</link>
		<comments>http://diabetes-symptoms-treatment.com/2012/04/gsk-says-diabetes-treatment-progressing-in-trials/#comments</comments>
		<pubDate>Tue, 03 Apr 2012 18:57:07 +0000</pubDate>
		<dc:creator>George</dc:creator>
		
		<category><![CDATA[Diabetes Treatment]]></category>

		<guid isPermaLink="false">http://diabetes-symptoms-treatment.com/2012/04/gsk-says-diabetes-treatment-progressing-in-trials/</guid>
		<description><![CDATA[


Proactive Investors UK


GSK says diabetes treatment progressing in trialsProactive Investors UKPharmaceutical giant GlaxoSmithKline (LON:GSK) reported its diabetes treatment, albiglutide, has shown “topline results” in seven of its eight final stage studies. Albiglutide is an injectable form of the human peptide GLP-1 which helps maintain normal &#8230;GSK: Movement toward FDA filing with weekly diabetes treatmentHULIQGlaxoSmithKline Drug [...]]]></description>
		<wfw:commentRss>http://diabetes-symptoms-treatment.com/2012/04/gsk-says-diabetes-treatment-progressing-in-trials/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Biocon, Pfizer End Pact On Biosimilar Insulin Products</title>
		<link>http://diabetes-symptoms-treatment.com/2012/03/biocon-pfizer-end-pact-on-biosimilar-insulin-products/</link>
		<comments>http://diabetes-symptoms-treatment.com/2012/03/biocon-pfizer-end-pact-on-biosimilar-insulin-products/#comments</comments>
		<pubDate>Tue, 13 Mar 2012 18:02:11 +0000</pubDate>
		<dc:creator>George</dc:creator>
		
		<category><![CDATA[Diabetes Treatment]]></category>

		<guid isPermaLink="false">http://diabetes-symptoms-treatment.com/2012/03/biocon-pfizer-end-pact-on-biosimilar-insulin-products/</guid>
		<description><![CDATA[


Business Today


Biocon, Pfizer End Pact On Biosimilar Insulin ProductsWall Street JournalBiocon, India&#39;s biggest biotechnology company by revenue, is developing biosimilars for treating diseases like diabetes and cancer. It had sold Pfizer exclusive rights to sell recombinant human insulin, glargine, aspart and lispro diabetes-treatment &#8230;Is the Pfizer-Biocon deal coming apart?Daily News &#38; AnalysisPfizer scraps insulin deal [...]]]></description>
		<wfw:commentRss>http://diabetes-symptoms-treatment.com/2012/03/biocon-pfizer-end-pact-on-biosimilar-insulin-products/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Cocoa &#8216;may help strengthen skeletal muscle function&#8217;</title>
		<link>http://diabetes-symptoms-treatment.com/2012/03/cocoa-may-help-strengthen-skeletal-muscle-function/</link>
		<comments>http://diabetes-symptoms-treatment.com/2012/03/cocoa-may-help-strengthen-skeletal-muscle-function/#comments</comments>
		<pubDate>Sat, 03 Mar 2012 17:17:57 +0000</pubDate>
		<dc:creator>George</dc:creator>
		
		<category><![CDATA[Diabetes Treatment]]></category>

		<guid isPermaLink="false">http://diabetes-symptoms-treatment.com/2012/03/cocoa-may-help-strengthen-skeletal-muscle-function/</guid>
		<description><![CDATA[


Zee News


Cocoa &#39;may help strengthen skeletal muscle function&#39;Zee NewsWashington: Cocoa may enhance the skeletal muscle function in patients with advanced heart failure and type 2 diabetes, a new study has found. A small clinical trial led by researchers at UC San Diego School of Medicine and VA San Diego Healthcare &#8230;Epicatechin-enriched cocoa shows promise against [...]]]></description>
		<wfw:commentRss>http://diabetes-symptoms-treatment.com/2012/03/cocoa-may-help-strengthen-skeletal-muscle-function/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Lupin Settles Patent Dispute Over Glumetza Diabetes Treatment</title>
		<link>http://diabetes-symptoms-treatment.com/2012/02/lupin-settles-patent-dispute-over-glumetza-diabetes-treatment/</link>
		<comments>http://diabetes-symptoms-treatment.com/2012/02/lupin-settles-patent-dispute-over-glumetza-diabetes-treatment/#comments</comments>
		<pubDate>Thu, 23 Feb 2012 16:26:13 +0000</pubDate>
		<dc:creator>George</dc:creator>
		
		<category><![CDATA[Diabetes Treatment]]></category>

		<guid isPermaLink="false">http://diabetes-symptoms-treatment.com/2012/02/lupin-settles-patent-dispute-over-glumetza-diabetes-treatment/</guid>
		<description><![CDATA[


Zee News


Lupin Settles Patent Dispute Over Glumetza Diabetes TreatmentFox BusinessBY) Thursday said it has settled a patent infringement litigation with Santarus Inc. (SNTS) and DepoMed Inc. (DEPO) over the Glumetza extended-release tablets for diabetes treatment. The settlement allows Lupin to sell a generic version of Glumetza &#8230;Santarus and Depomed Announce Settlement with Lupin of GLUMETZA [...]]]></description>
		<wfw:commentRss>http://diabetes-symptoms-treatment.com/2012/02/lupin-settles-patent-dispute-over-glumetza-diabetes-treatment/feed/</wfw:commentRss>
		</item>
		<item>
		<title>BYDUREON™, First and Only Once-Weekly Type 2 Diabetes Treatment, Now &#8230;</title>
		<link>http://diabetes-symptoms-treatment.com/2012/02/bydureon%e2%84%a2-first-and-only-once-weekly-type-2-diabetes-treatment-now/</link>
		<comments>http://diabetes-symptoms-treatment.com/2012/02/bydureon%e2%84%a2-first-and-only-once-weekly-type-2-diabetes-treatment-now/#comments</comments>
		<pubDate>Mon, 13 Feb 2012 16:19:01 +0000</pubDate>
		<dc:creator>George</dc:creator>
		
		<category><![CDATA[Diabetes Treatment]]></category>

		<guid isPermaLink="false">http://diabetes-symptoms-treatment.com/2012/02/bydureon%e2%84%a2-first-and-only-once-weekly-type-2-diabetes-treatment-now/</guid>
		<description><![CDATA[


A Sweet Life


BYDUREON™, First and Only Once-Weekly Type 2 Diabetes Treatment, Now &#8230;Sacramento BeeThe US Food and Drug Administration (FDA) approved BYDUREON, the first and only once-weekly treatment for type 2 diabetes, on Jan. 27, 2012 as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.Amylin&#39;s New Type [...]]]></description>
		<wfw:commentRss>http://diabetes-symptoms-treatment.com/2012/02/bydureon%e2%84%a2-first-and-only-once-weekly-type-2-diabetes-treatment-now/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Autoantigen Tx Benefits Some Type 1 Diabetics</title>
		<link>http://diabetes-symptoms-treatment.com/2012/02/autoantigen-tx-benefits-some-type-1-diabetics/</link>
		<comments>http://diabetes-symptoms-treatment.com/2012/02/autoantigen-tx-benefits-some-type-1-diabetics/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 16:01:52 +0000</pubDate>
		<dc:creator>George</dc:creator>
		
		<category><![CDATA[Diabetes Treatment]]></category>

		<guid isPermaLink="false">http://diabetes-symptoms-treatment.com/2012/02/autoantigen-tx-benefits-some-type-1-diabetics/</guid>
		<description><![CDATA[


Family Practice News Digital Network


Autoantigen Tx Benefits Some Type 1 DiabeticsMedPage TodayAutoantigen treatment of new-onset type 1 diabetes was unsuccessful in preserving pancreatic beta-cell function overall, but the treatment did appear to help in certain prespecified patient subgroups, a phase III European study found.Type 1 Diabetes Treatment Disappoints in TrialU.S. News &#38; World ReportGAD-alum Antigen [...]]]></description>
		<wfw:commentRss>http://diabetes-symptoms-treatment.com/2012/02/autoantigen-tx-benefits-some-type-1-diabetics/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Wireless glucose monitor may transform diabetes care</title>
		<link>http://diabetes-symptoms-treatment.com/2012/01/wireless-glucose-monitor-may-transform-diabetes-care/</link>
		<comments>http://diabetes-symptoms-treatment.com/2012/01/wireless-glucose-monitor-may-transform-diabetes-care/#comments</comments>
		<pubDate>Mon, 23 Jan 2012 14:48:25 +0000</pubDate>
		<dc:creator>George</dc:creator>
		
		<category><![CDATA[Diabetes Treatment]]></category>

		<guid isPermaLink="false">http://diabetes-symptoms-treatment.com/2012/01/wireless-glucose-monitor-may-transform-diabetes-care/</guid>
		<description><![CDATA[


Enterprise News (blog)


Wireless glucose monitor may transform diabetes careEnterprise News (blog)Including key relatives of people with diabetes in diabetes care is seen as critical to good management of the disease. This includes parents of diabetic children or the adult relatives of elderly people with diabetes. &#8220;Having up to the minute testing &#8230;and more&#160;&#187;



More details can [...]]]></description>
		<wfw:commentRss>http://diabetes-symptoms-treatment.com/2012/01/wireless-glucose-monitor-may-transform-diabetes-care/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

